Life Science Finance and Investment Briefing

The Life Science Finance & Investment Briefing is an essential gathering for entrepreneurs, CEOs, and financial directors looking to navigate the complex funding landscape of the biotech and medtech industries. Hosted in the heart of Cardiff, this MediWales event demystifies the various stages of capital raising—from seed funding and angel investment to venture capital and public grants. The briefing is designed to provide actionable intelligence on how to make a life science business "investment-ready."

The program features a diverse lineup of speakers, including representatives from the Development Bank of Wales, private equity firms, and successful founders who have recently completed significant funding rounds. These experts will provide a deep dive into what investors are currently looking for in the Welsh life science sector, with a particular focus on intellectual property (IP) valuation and clinical validation milestones. Attendees will also learn about the various tax incentives and R&D grants available through both the Welsh and UK governments.

A key highlight of the briefing is the "Investor Panel Q&A," where audience members can directly challenge a panel of funders on their investment criteria and current market sentiment. This is followed by an afternoon of "Speed-Dating for Investment," allowing selected start-ups to have five-minute introductory pitches with active investors in a low-pressure environment. For established firms, the briefing offers guidance on exit strategies, including mergers, acquisitions, and initial public offerings (IPOs).

In a sector where the cost of research and development is high and the time to market is long, securing the right financial partner is crucial. This event provides the networking and knowledge necessary to fuel the next generation of Welsh life science success stories, ensuring that groundbreaking medical research has the financial backing to reach the patients who need it most.